<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00552162</url>
  </required_header>
  <id_info>
    <org_study_id>NOTES HMO-CTIL</org_study_id>
    <secondary_id>21-2.11.07</secondary_id>
    <nct_id>NCT00552162</nct_id>
  </id_info>
  <brief_title>NOTES Transvaginal Cholecystectomy and Appendectomy</brief_title>
  <official_title>NOTES Transvaginal Cholecystectomy and Appendectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <brief_summary>
    <textblock>
      Natural Orifice Translumenal Endoscopic Surgery (NOTES) is considered by many leading expert&#xD;
      surgeons to be the next step in MIS (Minimally Invasive Surgery). This is a rapidly evolving&#xD;
      area of preclinical research and several groups worldwide are developing this surgical&#xD;
      approach together with industry support. In this new surgical technique, abdominal operations&#xD;
      are performed using the oropharynx, rectum, or vagina as the ports of entry to the peritoneal&#xD;
      cavity instead of incisions on the abdominal wall. NOTES offers all the advantages of&#xD;
      minimally invasive surgery (MIS) and also completely eliminates trauma to the abdominal wall&#xD;
      and the numerous complications of abdominal wall incisions. A NOTES procedure eliminates any&#xD;
      visible scar and could also potentially reduce post operative pain due to the elimination of&#xD;
      abdominal wall trauma.&#xD;
&#xD;
      In this trial we intend to operate healthy women who need to undergo cholecystectomy or&#xD;
      appendectomy. The operations will be performed through the vagina as the access port to the&#xD;
      peritoneum and it will be monitored with laparoscopic vision for safety reasons.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">January 1, 2018</completion_date>
  <primary_completion_date type="Actual">January 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL APPROACH TO MINIMALLY INVASIVE SURGICAL TECHNIQUES</measure>
    <time_frame>continuous</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>TO ASSESS PAIN ASSOCIATED WITH TRANSVAGINAL APPROACH</measure>
    <time_frame>continuous</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Gallbladder Diseases</condition>
  <condition>Appendicitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NOTES Transvaginal cholecystectomy The gallbladder will be dissected free and will be removed through an incision in the vagina.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NOTES Transvaginal Appendectomy. The appendix will be dissected free and will be removed through an incision in the vagina.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>NOTES Transvaginal Cholecystectomy</intervention_name>
    <description>The gallbladder will be dissected free and will be removed through an incision in the vagina.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>NOTES Transvaginal Appendectomy</intervention_name>
    <description>The appendix will be dissected free and will be removed through an incision in the vagina.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for group #1 Transvaginal cholecystectomy:&#xD;
&#xD;
          1. Females between the ages of 18 and 50&#xD;
&#xD;
          2. Diagnosis of gallstone disease which requires cholecystectomy&#xD;
&#xD;
          3. ASA class 1&#xD;
&#xD;
        Exclusion Criteria for group #1 Transvaginal cholecystectomy:&#xD;
&#xD;
          1. Pregnant women&#xD;
&#xD;
          2. Morbidly obese patients (BMI &gt; 35)&#xD;
&#xD;
          3. Patients who are taking immunosuppressive medications and/or immunocompromised&#xD;
&#xD;
          4. Patients with severe medical comorbidities will be excluded.&#xD;
&#xD;
          5. Patients with a presumed gallbladder polyps, mass or tumor&#xD;
&#xD;
          6. Patients with a history of prior open abdominal or transvaginal surgery.&#xD;
&#xD;
          7. Patients with a prior history of peritoneal or vaginal trauma&#xD;
&#xD;
          8. Patients with a history of ectopic pregnancy, pelvic inflammatory disease, or severe&#xD;
             endometriosis&#xD;
&#xD;
          9. Patients with known common bile duct stones&#xD;
&#xD;
         10. Patients on blood thinners or aspirin or abnormal blood coagulation tests&#xD;
&#xD;
        Inclusion Criteria for group #2 Transvaginal appendectomy:&#xD;
&#xD;
          1. Clinical diagnosis of appendicitis&#xD;
&#xD;
          2. Emergency room evaluation within 36 hours of the onset of pain&#xD;
&#xD;
          3. ASA Classification&#xD;
&#xD;
        Exclusion Criteria for group #2 Transvaginal appendectomy:&#xD;
&#xD;
          1. pregnant women&#xD;
&#xD;
          2. Morbidly obese patients (BMI &gt;35)&#xD;
&#xD;
          3. Patients who are taking immunosuppressive medications or are immunocompromised&#xD;
&#xD;
          4. Patients with evidence of an abdominal abscess or mass&#xD;
&#xD;
          5. Patients who present with a clinical diagnosis of sepsis or peritonitis&#xD;
&#xD;
          6. Patients who have a history of prior open abdominal surgery or prior transvaginal&#xD;
             surgery.&#xD;
&#xD;
          7. Patients who endorse a history of ectopic pregnancy, pelvic inflammatory disease&#xD;
             (PID), or severe endometriosis&#xD;
&#xD;
          8. Patients with diffuse peritonitis on clinical exam&#xD;
&#xD;
          9. Previous trauma to the perineal area&#xD;
&#xD;
         10. Patients on blood thinners or aspirin or abnormal blood coagulation tests&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoav Mintz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>12000</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <study_first_submitted>October 31, 2007</study_first_submitted>
  <study_first_submitted_qc>October 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2007</study_first_posted>
  <last_update_submitted>July 28, 2020</last_update_submitted>
  <last_update_submitted_qc>July 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
    <mesh_term>Gallbladder Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

